Is more always better? Dose effect in a multidomain intervention in older adults at risk of dementia

Alzheimers Dement. 2022 Nov;18(11):2140-2150. doi: 10.1002/alz.12544. Epub 2022 Jan 20.

Abstract

Background: Little is known regarding the dose-response function in multidomain interventions for dementia prevention.

Method: The Multidomain Alzheimer Preventive Trial is a 3-year randomized controlled trial comprising cognitive training, physical activity, nutrition, and omega-3 polyunsaturated fatty acids for at-risk older adults. The dose delivered (number of sessions attended) was modeled against global cognition, memory, and fluency in 749 participants. Interaction effects were assessed for age, sex, education, dementia score (CAIDE), frailty score, and apolipoprotein E (APOE) ε4 status.

Results: The dose-response models were non-linear functions indicating benefits up to about 12 to 14 training hours or 15 to 20 multidomain sessions followed by a plateau. Participants who benefited from a higher dose included women, younger participants, frail individuals, and those with lower education or lower risk of dementia.

Discussion: The non-linear function indicates that a higher dose is not necessarily better in multidomain interventions. The optimal dose was about half of the potentially available sessions.

Keywords: cognitive aging; cognitive decline; cognitive training; dementia; dosage; dose-response; intervention; multidomain; prevention.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alzheimer Disease* / prevention & control
  • Apolipoprotein E4 / genetics
  • Cognition
  • Cognition Disorders*
  • Exercise
  • Fatty Acids, Omega-3*
  • Female
  • Humans
  • Male

Substances

  • Apolipoprotein E4
  • Fatty Acids, Omega-3

Grants and funding